Effects of sublingual immunotherapy for Dermatophagoides farinae on Th17 cells and CD4+CD25+ regulatory T cells in peripheral blood of children with allergic asthma

International Forum of Allergy and Rhinology

Volumn 4, Issue 5, 2014, Pages 371-375

  Tian, Man ^a   Wang, Yu ^a   Lu, Yueqing ^a   Jiang, Yan He ^a   Zhao, De Yu ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Asthma; Children; Dermatophagoides farinae drops; Th17 cells

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; HOUSE DUST ALLERGEN; PLACEBO; PREDNISONE; STEROID; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DOUBLE BLIND PROCEDURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PEDIATRIC HOSPITAL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SCORING SYSTEM; SUBLINGUAL IMMUNOTHERAPY; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; ANIMAL; ASTHMA; CELL CULTURE; DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; PROCEDURES; SUBLINGUAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ANIMALS; ANTIGENS, CD4; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CELLS, CULTURED; CHILD; DERMATOPHAGOIDES FARINAE; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TREATMENT OUTCOME;

EID: 84899634986     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21305     Document Type: Article

References (18)

1. Halloy JL. [Sublingual hyposensitization]. Rev Med Brux. 2004;25:A256-A258. [French]
2. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147-S334.
3. Passalacqua G, Guerra L, Pasquali M, Lombardi C, Canonica GW. Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol. 2004;93:3-12.
4. Ebner C, Feldner H, Ebner H, Kraft D. Sensitization to storage mites in house dust mite (Dermatophagoides pteronyssinus) allergic patients. Comparison of a rural and an urban population. Clin Exp Allergy. 1994;24:347-352.
5. Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol. 2006;120:164-170.
6. Leu KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol. 2006;17:408-415.
7. Ozdemir C, Yazi D, Gocmen I, et al. Efficacy of long term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol. 2007;18:508-515.
8. Calamita Z, Saconato H, Pelá AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy. 2006;61:1162-1172.
9. Provoost S, Maes T, van Durme YM, et al. Decreased FOXP3 protein expression in patients with asthma. Allergy. 2009;64:1539-1546.
10. Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy. 2009;39:1314-1323.
11. Finotto S. T-cell regulation in asthmatic diseases. Chem Immunol Allergy. 2008;94:83-92.
12. Wakashin H, Hirose K, Maezawa Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med. 2008;178:1023-1032.
13. + regulatory T cells is interleukin 10 dependent. J Exp Med. 2005;202:1539-1547.
14. Eifan AO, Akkoc T, Yildiz A, et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy. 2010;40:922-932.
15. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy. 2005;60:4-12.
16. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132.
17. Reiner SL. Development in motion: helper T cells at work. Cell. 2007;129:33-36.
18. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.